FDA Eli Lilly - Search News

Eli Lilly is offering weight loss drug Zepbound

The Wall Street Journal on MSN · 10h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

Hosted on MSN · 11h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

MarketWatch on MSN · 16h

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will also be adding two new doses, as competition in the space continues to heat up.

14hon MSN

Why Eli Lilly Stock Popped Today

Eli Lilly ( LLY 2.31%) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

M&A News: Eli Lilly (LLY) Expands IBD Pipeline with Organovo’s FXR Program

The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...

FiercePharma1d

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Eli Lilly is offering weight loss drug Zepbound

Trending now